The majority of the genome is noncoding and was thought to be nonfunctional. However, it is now appreciated that transcriptional control of protein coding genes resides within these noncoding regions. Thousands of genes encoding long intergenic noncoding RNAs (lincRNAs) have been recently identified throughout the genome, which positively or negatively regulate transcription of neighboring target genes. Both TMEVPG1 and its mouse ortholog encode lincRNAs and are positioned near the IFN-g gene (IFNG) . In this study, we show that transcription of both mouse and human TMEVPG1 genes is Th1 selective and dependent on Stat4 and T-bet, transcription factors that drive the Th1 differentiation program. Ifng expression is partially restored in Stat4
Tbx21
2/2 cells through coexpression of T-bet and Tmevpg1, and Tmevpg1 expression contributes to, but alone is not sufficient to, drive Th1-dependent Ifng expression. Our results suggest that TMEVPG1 belongs to the general class of lincRNAs that positively regulate gene transcription. The Journal of Immunology, 2012, 189: 2084-2088.
T he immune system is directly responsible for protection against invading pathogens, including bacteria and viruses. Production of IFN-g by CD4 + Th1 cells, CD8 + T cells, NK cells, and NKT cells dictates the ability to clear intracellular infections and promote tumor immunity. IFNG expression is the result of successful coordination of histone modifications, trans-activating factors, and cis regulatory elements, including distal conserved noncoding sequences (1) (2) (3) . A naive CD4 + T cell initiates a Th1 polarizing program upon antigenic stimulation in the presence of the cytokine IL-12, leading to the activation of the JAK/STAT pathway components STAT1 and STAT4 (4). These molecules promote transcription of the master Th1 transcription factor, T-bet (5, 6), contributing to maintenance of IFNG locus permissivity as well as repression of the IL4 locus through covalent chromatin modifications (7) . Understanding how the IFNG locus is regulated by noncoding elements of the genome, particularly in the context of Th1 cell differentiation, has been an area of extensive investigation.
Long intergenic noncoding RNAs (lincRNAs) are a new species of regulatory RNAs that exist throughout the genome, but the understanding of their functions is incomplete (8) .
Initial findings indicate that thousands of lincRNAs exist in the vertebrate genome. In general, lincRNA genes are conserved across species, are positioned near their target protein coding genes, and impact a variety of compartmentalized biological systems. For example, XIST is required for the process of X chromosome inactivation in females. With the assistance of six additional lincRNAs, XIST "paints" the inactive chromosome with repressive histone marks silencing transcription (9) (10) (11) . HOTAIR and AIR regulate the HOXD and Igf2r loci, respectively, and are critical for development by modulating expression of these essential transcription factors. Recent evidence suggests that HOTAIR regulates expression of the HOXD locus by acting as a scaffold for histone-modifying enzyme recruitment (12) (13) (14) (15) . LincRNA-p21 expression is enhanced by the potent tumor suppressor p53 and then subsequently represses transcription of genes downstream of p53 signaling (16) . To date, few lincRNAs with enhancer function have been described (17, 18) . The function of lincRNAs in the immune system has not been actively investigated. A genome-wide screen identified a cluster of lincRNAs predicted to function in the immune system based on the proximity to genes known to encode proteins with immune function (19) . Additionally, independent noncoding RNA screens of activated CD8 + T cells and SARScoronavirus-infected cells have been conducted (19) ; however, the functional biology of these lincRNAs has not been determined.
TMEVPG1, a lincRNA transcript, was initially identified in the context of Theiler's virus infection whereby mice deficient in TMEVPG1 expression were unable to control the intracranial viral infection (20) . In this study, we describe TMEVPG1 as a Th1-specific lincRNA that requires Stat4 and T-bet for active transcription and contributes to the transcription of the gene encoding IFN-g. , and DO11.10.Tbx21 2/2 splenocytes (1 3 10 6 cells/ml) were stimulated with immobilized anti-CD3 (2C11; American Type Culture Collection) or OVA 323-339 peptide Ag (10 mg/ml) under Th1 (10 ng/ml IL-12 and 10 mg/ml anti-IL-4, 11B11; American Type Culture Collection), Th2 (10 ng/ml IL-4 and 10 mg/ml anti-IFN-g, R4-642; American Type Culture Collection), Th17 (10 ng/ml IL-6, 10 ng/ml IL-23, 1 ng/ml TGF-b, and 10 mg/ml anti-IFN-g), or Th22 (5 ng/ml IL-1b, 10 ng/ml IL-6, and 5 ng/ml TNF-a) polarizing conditions for 3 d. CD4
+ T cells were purified by positive selection (Miltenyi Biotec). Human or mouse cells were restimulated to generate effector cells by the addition of 50 ng/ml PMA and 1 mM ionomycin for 6 h or peptide Ag as described in Results.
RNA isolation and quantitative RT-PCR
Total RNA was isolated with TRI Reagent (Ambion). cDNA was synthesized with the SSRIII kit (Invitrogen). Transcript levels were determined by SYBR Green quantitative RT-PCR (qPCR) using the following primer pairs: human TMEVPG1, forward, 59-AAACGCTGGAGGAGAAGTCA-39, reverse, 59-TTCTCCTCCAGCGTTTTACG-39; mouse Tmevpg1, forward, 59-CCTG-AAAATCACCATGCACA-39, reverse, 59-GTTTTCGGGATGTCGTCA-AA-39. Human and murine message levels are expressed as the ratio to GAPDH (or Gapdh) transcript levels calculated directly from the threshold cycle.
Small interfering RNA knockdown
Silencer Select small interfering RNA (siRNA) duplexes (Ambion) were designed against the 59 Tmevpg1 sequence: siRNA 1, sense, 59-GAGAAGA-GCCUGAGAGAAATT-39, antisense, 39-TTCUCUUCUCGGACUCUC-UUU-59; siRNA 2, sense, 59-GCAGACUAAACUAGAUAGUTT-39, antisense, 39-TTCGUCUGAUUUGAUCUAUCA-59. Ifng siRNA (ID no. 158238) and nonspecific scramble siRNA (sense, 59-CAACUGGGACACAUGUGU-UTT-39, antisense, 39-TTGUUGACCCUGUGUACACAA-59) were used as controls. siRNA duplexes (30 pmol) were nucleofected into cells according to the manufacturer's instructions (Lonza). After 4 h recovery, cells were cultured (5 3 10 5 cells/ml) under Th1 conditions for 3 d before restimulation. IFN-g was measured in culture supernatants by ELISA (BD OptEIA; BD Biosciences).
Tmevpg1 sequencing and overexpression
Tmevpg1 cDNA clone AA162222 (Open Biosystems) was sequenced at the Vanderbilt Sequencing Facility. Full-length Tmevpg1 was cloned into the pcDNA3.1/myc-His A overexpression vector (Invitrogen). CMV-Tmevpg1, CMV-Tbx21, or CMV-empty vectors were transfected (1 mg/10 6 cells) into polarized splenocytes using Amaxa nucleofection (Lonza).
Statistical analysis
Statistical significance was determined by a Student t test.
Results

Selective expression of TMEVPG1 and its murine ortholog under Th1 polarizing conditions
Utilizing the University of California, Santa Cruz genome browser configuration we identified a gene, AK124066, also named TMEVPG1, which is predicted to transcribe a spliced, noncoding mRNA transcript and is positioned ∼170 kb from the IFNG coding region (Fig. 1A) . The 33-kb-long TMEVPG1 gene is comprised of four exons and encodes an mRNA of 1791 bp in length. TMEVPG1, similar to IFNG, possesses multiple Th1-specific DNAse I hypersensitivity sites at its promoter as well as epigenetic histone marks, H3K9 acetylation and H3K4 mono-and trimethylation, that are known to be associated with active transcription. Both TMEVPG1 and its mouse ortholog are located on the opposing strand to IFNG. The transcriptional start site of mouse Tmevpg1 is positioned 117 kb from the Ifng transcriptional start site and is spliced into a mature transcript 918 bp in length. The promoter region and first intron of Tmevpg1 also exhibit considerable sequence conservation with human TMEVPG1. These data are consistent with the possibility that TMEVPG1 encodes a lincRNA transcript selectively expressed in Th1 cells relative to Th2 cells.
To address this possibility, human CD4 + T cells were stimulated in vitro under Th1 or Th2 polarizing conditions + effector Th1 cells after restimulation with PMA and ionomycin. Results are expressed as the means 6 SD of three independent experiments. **p # 0.01, ***p # 0.001. for 3 d, followed by 2 d additional culture with IL-2 before restimulation with PMA and ionomycin. Transcript levels of IFNG, TMEVPG1, and GAPDH were determined by qPCR. Transcript levels of IFNG and TMEVPG1 were substantially greater in Th1 cultures compared with Th2 cultures (Fig.  1B, 1C) . We also determined transcript levels of IFNG and TMEVPG1 in PBMCs from healthy human control subjects and compared transcript levels by linear regression. We found a positive correlation between IFNG and TMEVPG1 transcript levels relative to GAPDH (Fig. 1D) . Taken together, these results demonstrate that, similar to IFNG, TMEVPG1 transcript levels are selectively expressed in Th1 cultures relative to Th2 cultures. The linear regression analysis further indicates a strong association between IFNG and TMEVPG1 transcript levels in PBMCs.
To assess whether murine Tmevpg1 was also preferentially expressed in polarized Th1 cells, we measured Tmevpg1 transcript levels in total splenocytes cultured under Th1 or Th2 polarizing conditions. RNA was isolated after 3 d in culture at the peak of Ifng expression during primary stimulation. Tmevpg1 and Ifng message levels were measured by qPCR. Consistent with our results in human lymphocytes, Tmevpg1 transcript levels were significantly greater in Th1 cells than in Th2 cells (Fig. 1E) . Tmevpg1 transcript levels were also analyzed in Th17 and Th22 polarized cells to confirm Th1 specificity (Fig. 1E) . We also restimulated Th1 effector cells with PMA and ionomycin and followed Tmevpg1 transcript levels over time. IL-2 was added to these cultures to sustain viability. Restimulation resulted in a marked increase in Tmevpg1 transcript levels that was sustained over several days (Fig. 1F) . In contrast to what we observed in Th1 effector cultures, Tmevpg1 transcript levels were undetectable in effector CD8 + T cells polarized under Th1 culture conditions, which produced a significant amount of IFN-g (1.7-fold Gapdh transcript levels measured by qPCR).
We conclude from these experiments that Th1 selective Tmevpg1 expression is conserved between murine and human lymphocytes but is not expressed by CD8 + T cells under these culture conditions. Furthermore, restimulation of Th1 cells results in greater Tmevpg1 expression levels than observed in primary Th1 cultures, implicating a role for Tmevpg1 in effector Th1 cells.
Tmevpg1 is regulated by Th1 transcription factors
Th1 selective expression of IFN-g in our model system is dependent on the transcription factors Stat4 and T-bet. Because Tmevpg1 also displays selective Th1 expression, we determined whether Tmevpg1 expression was also dependent on Stat4 and T-bet. To do so, we isolated splenocytes from DO11.10. peptide and IL-12. After 3 d, CD4
+ T cells were purified and restimulated with OVA 323-339 peptide for 48 h. As expected, Ifng transcript levels were substantially diminished in Th1 cells in the absence of Stat4 or T-bet compared with the DO11.10 wild-type control mice ( Fig. 2A) . Tmevpg1 transcript levels were also substantially reduced in T cells deficient in either Stat4 or T-bet ( Fig. 2A) .
Influence of Tmevpg1 on Ifng transcription
LincRNAs have been clustered into two functionally distinct categories: repressors and enhancers of transcription of protein coding genes. We sought to determine the function of Tmevpg1 in Th1 cells via siRNA-mediated knockdown of Tmevpg1. Nucleofection of Tmevpg1-specific siRNA duplexes 1 and 2 resulted in a reduction of Tmevpg1 (Fig. 2B) and Ifng (Fig.  2C ) transcript levels relative to the scramble siRNA-transfected polarized splenocytes. Knockdown of Tmevpg1 by siRNA duplex 1 or siRNA duplex 2 resulted in a 2-or 4-fold reduction in IFN-g protein, respectively, relative to transfection with a nonspecific scrambled siRNA (Fig. 2D) . Knockdown with Ifng siRNA resulted in a similar decrease in IFN-g protein concentrations. Nucleofection with both Tmevpg1 siRNA duplexes 1 and 2 caused a comparable reduction in Tmevpg1 transcript levels whereas siRNA knockdown of Ifng did not affect transcript levels of Tmevpg1. Our conclusion is that Tmevpg1 plays a role in Ifng expression by Th1 cells.
Based on the results from the siRNA knockdown experiments, we determined whether overexpression of Tmevpg1 was sufficient to induce Ifng transcription. Full-length Tmevpg1 was cloned into a CMV expression plasmid. Total BALB/c-J splenocytes were stimulated with anti-CD3 under nonpolarizing conditions (Th0) or under Th1 or Th2 polarizing conditions for 3 d. CD4
+ T cells were isolated and CMV-Tmevpg1 or CMV-empty vectors were then transfected (1 mg plasmid/10 6 cells). After a period of rest, cells were restimulated with PMA and ionomycin. Nucleofection of CMV-Tmevpg1 into primary Th1 cells resulted in an increased expression of Tmevpg1 compared with the empty vector control (Fig. 3A) . Ectopic expression of Tmevpg1 in primary CD4 + T cells resulted in no significant increase in IFN-g protein in Th0, Th1, or Th2 cells relative to transfection with an empty vector control (Fig. 3B) . We further examined whether Tmevpg1 was sufficient to restore Ifng transcript expression in the absence of Stat4 and Tbet. CMV-Tmevpg1, CMV-Tbx21, or CMV-empty vector plasmids were transfected into Th1 polarized BALB/c-J. Stat4
Tbx21
2/2 splenocytes. After a period of rest, cultures were restimulated with PMA and ionomycin. Tmevpg1, Tbx21, and Ifng transcript levels were determined by qPCR. We observed Tmevpg1 expression to be restored by ectopic expression of T-bet alone in the BALB/c-J.Stat4 2/2 Tbx21 2/2 cells ( Fig  4A) . CMV-Tmevpg1 and CMV-Tbx21 cotransfection resulted in a substantial increase in Ifng transcript levels relative to transfection of CMV-Tmevpg1 or CMV-Tbx21 alone (Fig.  4C) . We conclude from these experiments that overexpression of Tmevpg1 in trans alone is not sufficient to induce increased Ifng transcription in Th0, Th1, or Th2 cells or in Stat4
2/2 cells except in the presence of T-bet.
Discussion
Presently, lincRNAs segregate into two functional categories that either repress or enhance the transcription of protein coding genes. To summarize our results, Tmevpg1 and its human ortholog are expressed selectively in Th1 cells relative to Th2, Th17, and Th22 cells, and expression is dependent on the Th1-specific transcription factors Stat4 and T-bet. Our results also demonstrate that Tmevpg1 influences Ifng transcription in response to the Th1 differentiation program. In contrast, ectopic expression of Tmevpg1 does not increase Ifng transcript levels in Th0, Th1, or Th2 cells; however, Tmevpg1 is able to partially restore Ifng expression when T-bet is also overexpressed. One possible interpretation is that Tmevpg1 must be expressed from its endogenous locus, or in cis, to stimulate Ifng transcription. A second possible interpretation, which our data favor, is that Tmevpg1 must act in concert with T-bet, or other critical trans-activating factors, to influence Ifng transcription.
Other studies of enhancer lincRNAs are consistent with our results and these lincRNAs also fail to stimulate transcription of protein coding genes in trans or require additional transactivation factors to drive their transcription (17) . A general emerging model is that cell type-specific transcription factors bind to lincRNA promoters to drive their transcription. The lincRNAs bind to ubiquitous proteins required to establish the epigenetic code, and by mechanisms that are incompletely understood they direct these proteins to their target protein-coding genes (18, 20) . This model does not rule out the possibility that these cell type-specific transcription factors also target protein-coding genes. Our results demonstrate that one lincRNA, Tmevpg1, contributes to Ifng expression as part of the Th1 differentiation program. We predict that additional lincRNAs play critical roles in developmental programs required to establish the different functions of the immune system.
